Q THERAPEUTICS

q-therapeutics-logo

Q Therapeutics is a development stage company, engages in the development of human cell-based therapies for the treatment of degenerative diseases of the brain and spinal cord. The company develops Q-Cells that is intended for the treatment of amyotrophic lateral sclerosis, multiple sclerosis, transverse myelitis, traumatic spinal cord injury, and Parkinson’s disease, as well as for Alzheimer’s disease, traumatic brain injury, cerebral palsy, Leukodystrophies and central nervous system storage diseases, and peripheral neuropathies. Q Therapeutics is headquartered in Salt Lake City, Utah.

#SimilarOrganizations #People #Financial #Website #More

Q THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Therapeutics

Founded:
2004-01-01

Address:
Salt Lake City, Utah, United States

Country:
United States

Website Url:
http://www.qthera.com

Total Employee:
1+

Status:
Active

Contact:
801-582-5400

Email Addresses:
info@qthera.com

Total Funding:
24.22 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Microsoft Exchange Online Office 365 Mail JsDelivr Microsoft Azure DNS


Similar Organizations

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

Current Employees Featured

deborah-a-eppstein_image

Deborah A. Eppstein
Deborah A. Eppstein Director, President & CEO @ Q Therapeutics
Director, President & CEO

mahendra-rao_image

Mahendra Rao
Mahendra Rao Scientific Co-founder, Chief Strategy Officer @ Q Therapeutics
Scientific Co-founder, Chief Strategy Officer

not_available_image

Steven J. Borst
Steven J. Borst Chief Financial Officer @ Q Therapeutics
Chief Financial Officer

Founder


mahendra-rao_image

Mahendra Rao

Acquisitions List

Date Company Article Price
2016-11-28 Degania Medical Degania Medical acquired by Q Therapeutics N/A

Investors List

university-of-utah-endowment_image

University of Utah Endowment

University of Utah Endowment investment in Venture Round - Q Therapeutics

epic-ventures_image

EPIC Ventures

EPIC Ventures investment in Venture Round - Q Therapeutics

salt-lake-life-science-angels_image

Salt Lake Life Science Angels

Salt Lake Life Science Angels investment in Venture Round - Q Therapeutics

qmanagement_image

Q management

Q management investment in Venture Round - Q Therapeutics

toucan-capital_image

Toucan Capital

Toucan Capital investment in Venture Round - Q Therapeutics

vspring-capital_image

vSpring Capital

vSpring Capital investment in Venture Round - Q Therapeutics

Official Site Inspections

http://www.qthera.com

  • Host name: 147.62.236.23.bc.googleusercontent.com
  • IP address: 23.236.62.147
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Qthera.com lookup results from whois.networksolutions.com server:
  • Domain created: 21st-Apr-2003
  • Domain updated: 24th-Apr-2024
  • Domain expires: 21st-Apr-2025 0 Years, 98 Days left
  • Website age: 21 Years, 266 Days
  • Registrar Domain ID: 97043258_DOMAIN_COM-VRSN
  • Registrar Url: http://networksolutions.com
  • Registrar WHOIS Server: whois.networksolutions.com
  • Registrar Abuse Contact Email: domain.operations@web.com
  • Registrar Abuse Contact Phone: +1.8777228662
  • Name server:
    • NS73.WORLDNIC.COM
    • NS74.WORLDNIC.COM

More informations about "Q Therapeutics"

Home | qthera

Q Therapeutics has adopted a unique approach to developing human cell-based therapies for debilitating – and currently incurable – diseases of the brain and spinal cord (the central …See details»

About - qthera

Dr. Parks brings to Q Therapeutics more than 30 years experience in life science research and its translation into therapeutic products. As a faculty member in the Department of Neurobiology …See details»

Q Therapeutics - Crunchbase Company Profile & Funding

Contact Email info@qthera.com Phone Number 801-582-5400 Q Therapeutics is a development stage company, engages in the development of human cell-based therapies for the treatment …See details»

Q Therapeutics Company Profile 2024: Valuation, Funding

Q Therapeutics General Information Description. Developer of novel stem cell therapy intended to treat debilitating CNS disease and injury. The company's cell therapies replace the insulating …See details»

Investors | qthera

See details»

Q Therapeutics - LinkedIn

Q Therapeutics | 440 followers on LinkedIn. Q has developed a human cell based therapeutic product to treat degenerative disorders of the brain and spinal cord. | Q Therapeutics is a …See details»

Q Therapeutics - Overview, News & Similar companies - ZoomInfo

Www.qthera.com. Revenue <$5 Million. Industry Manufacturing General Manufacturing . Recent News & Media. InVivo Therapeutics Announces Joint Research Collaboration w... Oct 2, 2018. …See details»

qthera.com - Home | qthera - Qthera - Sur.ly

Qthera.com most likely does not offer any adult content. Popular pages. Home | qthera Q-Cells® – our first cellular therapeutic candidate – are human glial progenitor cells that give rise to two …See details»

Goodwin biotech partners with Q Thera in ALS treatment project.

Jul 13, 2015 Goodwin Biotechnology is a biological contract development and manufacturing organization (CDMO) that offers cell line development, exploratory proof of concept projects, …See details»

Quethera - Crunchbase Company Profile & Funding

Quethera is a gene therapy company dedicated to improving the future treatment of common blinding eye diseases. Our initial focus is on developing therapies to reduce progressive visual …See details»

Pipeline - qthera

Q Therapeutics has a deep pipeline, with significant market potential backed by a strong intellectual property position. Q Therapeutics is actively preparing for first-in-human clinical …See details»

FDA Allows Q-Cells (R) for First-In-Human Transverse Myelitis Trial

Jul 25, 2017 Q Therapeutics, Inc., developer of clinical-stage cell therapies for central nervous system disease and injury, announced U.S. Food and Drug Administration allowance of its …See details»

QUALTHERA

At Qualthera, we are dedicated to providing innovative, custom medication solutions for both healthcare providers and patients. Our mission is to deliver quality therapy for life, ensuring …See details»

Quethera - Contacts, Employees, Board Members, Advisors & Alumni

Quethera is a gene therapy company dedicated to improving the future treatment of common blinding eye diseases.See details»

Therapeutic Focus | qthera

Our initial targets are orphan diseases, such as transverse myelitis and ALS, which benefit from an accelerated FDA approval process and market exclusivity.See details»

Quthero.com

In wounded skin, Q-peptide treatment accelerates cell migration and leads to a unique profile of cytokine secretion, enabling faster healing and deposition of new collagen.Q-peptide treatment …See details»

Quethera Company Profile 2024: Valuation, Investors ... - PitchBook

Quethera General Information Description. Developer of gene therapy technologies designed to improve the treatment of common blinding eye diseases. The company's technology focuses …See details»

Technology - qthera

The most common types of glial cells in the brain are: Astrocytes – Specialized cells that protect neurons by producing growth factors, removing toxins, protecting against damage, modulating …See details»

qthera.net

Qthera.netSee details»

News - qthera

Aug 21, 2014 Reversing Paralysis: Stem cell therapy aims to repair spinal cords afflicted by rare disorder. Oct 8, 2018, 8:00 AM EDT InVivo Therapeutics Announces Joint Research …See details»

linkstock.net © 2022. All rights reserved